Brief: Burning Rock Reports Q2 Revenues RMB 130.8 Mln, Up By 2.8%
Aug 31 (Reuters) - Burning Rock Biotech Ltd BNR.O :
* BURNING ROCK REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
* QTRLY REVENUES WERE RMB130.8 MILLION (US$19.5 MILLION),
REPRESENTING A 2.8% INCREASE
* RETAINS ITS FULL YEAR 2022 REVENUE GUIDANCE OF
APPROXIMATELY
RMB620 MILLION (US$92.6 MILLION) FOR NOW
* QTRLY LOSS PER SHARE FOR CLASS A AND CLASS B ORDINARY
SHARES RMB
2.50
Source text for Eikon: ID:nGNX10WKB0
Further company coverage: BNR.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Burning Rock Biotech
See all newsBurning Rock Biotech's Q2 revenue falls, net loss widens on central laboratory weakness
China's Burning Rock Biotech Q1 revenue falls on lower test volumes
China's Burning Rock Biotech Q4 net loss narrows as costs fall
Cancer diagnostics firm Burning Rock Biotech's Q3 revenue rises on pharma R&D growth
Brief: Burning Rock's Oncoguide™ Oncoscreen™ Plus CDX System Now Approved In Japan As A Companion Diagnostic For Capivasertib In Breast Cancer